BNTX vs IDXX
BioNTech SE vs Idexx Laboratories — AI-powered side-by-side comparison
VS
IDXX
Idexx Laboratories
69
Buy
| Metric | BNTX | IDXX |
|---|
| AI Score |
70
|
69
|
| Price |
$91.61
|
$546.21
|
| P/E Ratio |
-11.83×
|
38.69×
|
| ROE |
-5.7%
|
66.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
68.9%
|
62.4%
|
| Debt / Equity |
0.02×
|
0.68×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
55.9
|
33.3
|
| Beta |
1.278
|
1.542
|
| Expected Upside |
+6.1%
|
+5.4%
|
AI Committee View
Current Innellis committee reasoning for BNTX versus IDXX.
BNTX leads by 1 points.
BNTX scores 70/100 (Buy) versus IDXX at 69/100 (Buy).
BNTX Committee View
60% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
IDXX Committee View
75% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
- MACD histogram negative -- bearish momentum — Technical